Hypokalemia with Trifluoperazine at Therapeutic Dose
- PMID: 28615774
- PMCID: PMC5461850
- DOI: 10.4103/0253-7176.207315
Hypokalemia with Trifluoperazine at Therapeutic Dose
Abstract
This case report outlines a rare presentation of hypokalemia with therapeutic doses of trifluoperazine in a patient with schizophrenia. Although there was comorbid diabetes mellitus in the patient, its effect was ruled out subsequently. On recovery, rechallenge with trifluoperazine resulted in the same effect at a milder level. No cardiac abnormalities were detected with the presentation. Naranjo adverse drug reaction probability scale reported definite relation with the drug.
Keywords: Antipsychotic; hypokalemia; trifluoperazine.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Lam MH, Chau SW, Wing YK. High prevalence of hypokalemia in acute psychiatric inpatients. Gen Hosp Psychiatry. 2009;31:262–5. - PubMed
-
- Malik AR, Wolf PK, Ravasia S. Hypokalemia from risperidone and quetiapine overdose. Can J Psychiatry. 2005;50:76. - PubMed
-
- Hoorn EJ, van der Poel MF. Hypokalemic hypertension related to clozapine: A case report. J Clin Psychopharmacol. 2014;34:390–2. - PubMed
-
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources